The article says semaglutide does not significantly increase resting metabolic rate in most patients, and its own table lists the effect as minimal change or even a slight decrease, with no direct thermogenic action
Leung M, Wong VW, Hudson M, Leung DY
Key Takeaways Retatrutide has no official price: it's an investigational drug in Phase 3 clinical trials (Eli Lilly's TRIUMPH program) and is not FDA-approved Research peptide retatrutide costs roughly $40$120 per 5mg vial , translating to approximately $150$500/month at clinical-level doses Compounded retatrutide from telehealth or compounding pharmacies runs approximately $200$500/month Projected commercial pricing at launch (~20272028) is estimated at $1,000$1,500/month , benchmarked against Mounjaro/Zepbound Clinical trial enrollment provides free access to retatrutide
The consultation can be done either over the phone, video call or in-person in clinic
GLP-1 drugs imitate this process by enhancing insulin release and limiting excess glucose production by the liver